Full Press Release Details
argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024.
ARGX
argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024
Key Takeaway: argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024
Price reaction · baseline $395.4 (2024-02-20 close) · hit after-hours · 1 other ARGX headline(s) in the window, move may be shared
day 0 close · peak
+1.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis